Page last updated: 2024-12-08
1-methyl-3,4-dihydroisoquinoline
Description
## 1-Methyl-3,4-dihydroisoquinoline: A Versatile Building Block in Research
1-Methyl-3,4-dihydroisoquinoline is a **heterocyclic compound** with the following structure:
[Image of 1-Methyl-3,4-dihydroisoquinoline structure]
This compound holds significance in research due to its **versatility** and its presence in various **pharmacologically active molecules**.
**Key Features and Importance:**
* **Building Block for Complex Molecules:** Its structure provides a foundation for synthesizing diverse and complex organic compounds, including alkaloids, natural products, and pharmaceuticals.
* **Pharmacological Activity:** 1-Methyl-3,4-dihydroisoquinoline derivatives have shown promising biological activities:
* **Anti-inflammatory:** Some derivatives exhibit potent anti-inflammatory properties, making them potential candidates for treating various inflammatory diseases.
* **Antimicrobial:** Others exhibit antibacterial and antifungal activity, offering potential for developing new antibiotics.
* **Anticancer:** Certain derivatives show potential as anticancer agents, targeting specific pathways involved in tumor growth.
* **Neuroprotective Properties:** Some derivatives exhibit neuroprotective effects, suggesting potential use in treating neurodegenerative diseases like Alzheimer's and Parkinson's.
* **Study of Reaction Mechanisms:** Its unique chemical structure and reactivity make it an interesting subject for studying organic reaction mechanisms and developing new synthetic methodologies.
**Examples of Research Applications:**
* **Synthesis of Morphine Analogs:** 1-Methyl-3,4-dihydroisoquinoline serves as a starting material for synthesizing morphine analogs with potential analgesic activity.
* **Development of New Antidepressants:** Derivatives of this compound have been investigated for their antidepressant activity due to their ability to modulate neurotransmitter systems.
* **Exploration of Anti-Inflammatory Compounds:** Research continues to explore the potential of 1-Methyl-3,4-dihydroisoquinoline derivatives as novel anti-inflammatory drugs.
* **Study of Catalytic Reactions:** Its reactivity makes it an interesting target for studying catalytic reactions and developing novel catalysts.
**Overall:** 1-Methyl-3,4-dihydroisoquinoline remains a versatile building block in research, offering a foundation for developing novel compounds with various pharmacological activities. Its chemical structure and reactivity make it an attractive target for synthetic chemists, while its potential for therapeutic applications motivates further research.
1-methyl-3,4-dihydroisoquinoline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 231502 |
SCHEMBL ID | 30310 |
MeSH ID | M0467184 |
Synonyms (18)
Synonym |
nsc27893 |
2412-58-0 |
nsc-27893 |
1-methyl-3,4-dihydroisoquinoline |
AKOS006229266 |
SCHEMBL30310 |
1-methyl-3,4 dihydroisoquinoline |
(+/-) 1-methyl-3,4-dihydroisoquinoline |
1-methyl-3,4-dihydro-isoquinoline |
1-methyl-3,4-dihyroisoquinoline |
mfcd00047648 |
1-methyl-3,4,dihydroisoquinoline |
AMY3713 |
DTXSID30946947 |
CS-0152737 |
A924257 |
CAA41258 |
EN300-182056 |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.91
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.91 (24.57) | Research Supply Index | 2.56 (2.92) | Research Growth Index | 4.48 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 1 (9.09%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |